Filing Details
- Accession Number:
- 0001179110-15-008104
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-19 16:53:24
- Reporting Period:
- 2015-05-15
- Filing Date:
- 2015-05-19
- Accepted Time:
- 2015-05-19 16:53:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286370 | R Michael Minogue | C/O Abiomed, Inc., 22 Cherry Hill Drive Danvers MA 01923 | President, Ceo, Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock $.01 Par Value | Disposition | 2015-05-15 | 13,311 | $66.96 | 331,161 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-05-15 | 6,239 | $67.75 | 324,922 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-05-15 | 133 | $68.50 | 324,789 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $13.57 | 2007-06-01 | 2016-06-01 | 0 | 82,000 | Direct |
| Common Stock | Stock Option (right to buy) | $13.80 | 2009-05-23 | 2018-05-23 | 0 | 28,333 | Direct |
| Common Stock | Stock Option (right to buy) | $18.63 | 2009-06-15 | 2018-08-13 | 0 | 76,875 | Direct |
| Common Stock | Stock Option (right to buy) | $5.86 | 2010-05-28 | 2019-05-28 | 0 | 146,800 | Direct |
| Common Stock | Stock Option (right to buy) | $5.86 | 2010-05-28 | 2019-05-28 | 0 | 56,700 | Direct |
| Common Stock | Stock Option (right to buy) | $10.03 | 2011-06-03 | 2020-06-03 | 0 | 105,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $22.44 | 2013-05-22 | 2022-05-22 | 0 | 50,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2024-05-14 | 0 | 21,250 | Direct |
| Common Stock | Stock Option (right to buy) | $21.55 | 2015-05-14 | 2024-05-14 | 0 | 85,000 | Direct |
| Common Stock | Stock Option (right to buy) | $66.25 | 2016-05-13 | 2025-05-13 | 0 | 35,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2016-06-01 | 0 | 82,000 | Direct |
| 2018-05-23 | 0 | 28,333 | Direct |
| 2018-08-13 | 0 | 76,875 | Direct |
| 2019-05-28 | 0 | 146,800 | Direct |
| 2019-05-28 | 0 | 56,700 | Direct |
| 2020-06-03 | 0 | 105,000 | Direct |
| 2022-05-22 | 0 | 50,000 | Direct |
| 2024-05-14 | 0 | 21,250 | Direct |
| 2024-05-14 | 0 | 85,000 | Direct |
| 2025-05-13 | 0 | 35,000 | Direct |
Footnotes
- Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable based on the achievement of certain performance milestones.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan, solely for payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $66.4500 and $67.4300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $67.4500 and $68.1900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
